Gabriel Defang
Impact in
- Virology top 10%
- HIV Research and Treatment
- Infectious Diseases top 10%
- Viral Infections and Vectors
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Viral Infections and Vectors 7
- SARS-CoV-2 and COVID-19 Research 4
- Viral Infections and Outbreaks Research 3
-
- Influenza Virus Research Studies 7
- Respiratory viral infections research 5
- Co-authors
- Timothy Burgess (5 shared papers)Kanakatte Raviprakash (5 shared papers)Tahaniyat Lalani (4 shared papers)Nancy F. Crum‐Cianflone (4 shared papers)Lynn E. Eberly (3 shared papers)Christopher Duplessis (3 shared papers)Shuenn-Jue Wu (4 shared papers)Dennis J. Faix (3 shared papers)
- Journals
- Vaccine (5 papers)Scientific Reports (2 papers)Clinical Infectious Diseases (1 paper)Pathogens (1 paper)Human Vaccines (1 paper)
- Partner nations
- United StatesEgyptPakistan
In The Last Decade
Gabriel Defang
18 papers receiving 389 citations
Peers
Comparison fields: 5 of 72
- Virology 40
- Infectious Diseases 127
- Epidemiology 192
- Health 31
- Hepatology 28
Countries citing papers authored by Gabriel Defang
This map shows the geographic impact of Gabriel Defang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Defang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Defang more than expected).
Fields of papers citing papers by Gabriel Defang
This network shows the impact of papers produced by Gabriel Defang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Defang. The network helps show where Gabriel Defang may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Defang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 83 | |
| 2 | 2019 | 63 | |
| 3 | 2011 | 44 | |
| 4 | 2019 | 30 | |
| 5 | 2010 | 27 | |
| 6 | 2020 | 22 | |
| 7 | 2009 | 21 | |
| 8 | 2019 | 20 | |
| 9 | 2018 | 20 | |
| 10 | 2012 | 19 | |
| 11 | 2011 | 14 | |
| 12 | 2014 | 12 | |
| 13 | 2014 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2017 | 6 | |
| 16 | 2017 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2021 | 0 |
About Gabriel Defang
Gabriel Defang is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Molecular Biology and Virology, having authored 19 papers that have together received 403 indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (8 papers), Influenza Virus Research Studies (7 papers), Viral Infections and Vectors (7 papers), Respiratory viral infections research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Viral Infections and Outbreaks Research (3 papers), HIV Research and Treatment (2 papers) and Animal Virus Infections Studies (2 papers). The work is most often cited by research in Virology (40 citations), Infectious Diseases (127 citations), Epidemiology (192 citations), Health (31 citations) and Hepatology (28 citations). Gabriel Defang has collaborated with scholars based in United States, Egypt and Pakistan. Frequent co-authors include Timothy Burgess, Kanakatte Raviprakash, Tahaniyat Lalani, Nancy F. Crum‐Cianflone, Lynn E. Eberly, Christopher Duplessis, Shuenn-Jue Wu, Dennis J. Faix, Erik Iverson and Patrick J. Blair. Their work appears in journals such as Vaccine, Scientific Reports, Clinical Infectious Diseases, Pathogens and Human Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.